Current Litigation

PFAS AND AMERICA’S WATER SUPPLY “THE FOREVER CHEMICAL IS HERE TO STAY”

A MASS TORT NEWS WHITE PAPER Toxic ‘forever chemicals’ in tap water across the country- Who knew and when Environmental testing shows a class of extremely toxic chemicals called PFAS/PFOS are in the US water supply Why has the public not been informed By Mark A York September 22, 2020 “You may not recognize the name PFAS, short for poly and perfluoroalkyl substances, but you likely come into contact with it regularly, maybe multiple times a day You might even consume it” It is a silent chemical lurking in many areas of the USA, in drinking water, consumer products, and many other areas that are...

ETHICON TVM TRIAL (MDL 2327) STARTS IN CHARLESTON Sutphin vs. Ethicon 2:14-cv-01379

“A LEGACY TRIAL FROM TVM MDL 2327” Mass Tort News would like to welcome Jane Akre, as our senior contributor and writer on Women’s Health subjects as well as related litigation Jane is primarily known as the Editor of Mesh Medical Device News Desk, where she has been providing outstanding real-time reporting on TVM and other dockets that have impacted women for several years This is Jane’s first article published in Mass Tort News and we hope you will engage and follow Jane both here and via her Mesh Medical Device News Desk platform  Thank you Jane and welcome to Mass Tort News Ethicon TVM MDL...

Zantac Litigation Overview

Article Provided by Brenden Leydon Attorney at Wocl Leydon LLC The litigation over the harmful effects of Zantac (generic name is Ranitidine) is just getting underway, and it looks like it will lead to a significant number of cases What is Zantac/Ranitidine Ranitidine is an antacid which belongs to a class of drugs known as histamine-2 receptor agonists (H2 blockers) This medication was also available without a prescription It was used as a common treatment used for ulcers, heartburn, indigestion, and gastroesophageal reflux disease (GERD) It works by effectively blocking histamine receptors in the...

Nuedexta: Drug Being Pushed “Off-Label” On Elderly In Nursing Homes = $116 Million Settlement

Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year  by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe Off-label use is when a company offers and markets a drug for reasons other than what it was initially approved for by the FDA The vast majority of the “off-label” related payments to nursing homes are coming straight from the federal government Both civil and criminal actions are often...

JUUL: How Big Tobacco bought into a company that killed teens for profit!

The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s principal advertising themes have been closely aligned with that of traditional tobacco advertising” Why is Juul so popular among teens Although Juul demands age verification upon navigating to its website and holds a firm stance...

Breast implant

FDA FINALLY MOVING ON BREAST IMPLANTS: Once again lagging behind the world in healthcare oversight

(MASS TORT NEWS) US health officials are now finally taking an assertive position regarding women getting breast implants by stating that stronger warnings and more details about the possible risks and complications including links to cancer Why has there been a multi-year FDA delay on this in the USA The Food and Drug Administration said that manufacturers should add a warning highlighted by a “black box warning” - the most serious type – to be provided to women receiving or considering implants The primary makers of breast implants approved for use in the United States include: Allergan,...

Why Does the FDA Ignore “Off-Label” Drug Marketing While Thousands Die Every Year?

Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS)  Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses They also engaged in a parallel strategy, where they were influencing the FDA and other policy making agencies behind the scenes in Washington DC Big Pharma was paying millions to lobbyists, making campaign donations and generally buying influence as they...